MedPath

Test-retest repeatability of quantitative radiomics features of FDG PETCT studies in patients with diffuse large B cell lymphoma

Recruiting
Conditions
Diffuse Large B-Cell lymphoma
Registration Number
NL-OMON25380
Lead Sponsor
VUmc
Brief Summary

Results will be published in an international peer-reviewed journal

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Patient age 18 years or older
-Diagnosed with diffuse large B cell lymphoma
-At least one tumour with diameter ? 3cm (to minimize partial volume effects)
-Able to remain supine for 30 minutes in the PET-CT scanner
-Written and signed informed consent

Exclusion Criteria

-Chemotherapy in the past 4 weeks
-Multiple malignancies
-Pregnant or lactating patients
-Metal implants (e.g. pacemakers)
-Any medical, physiological or social condition that may interfere with the subject’s safety and participation in the study, will lead to exclusion from this study

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
test-retest repeatability of radiomics features
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath